VISITECT -Model CD4 -In-Vitro Diagnostic Test
VISITECT CD4 in-vitro diagnostic test is for use as an aid in the management of patients with pre-diagnosed HIV infection. This visually read test is designed to be used at the point-of-care and therefore has utility in decentralised diagnostic settings. The VISITECT® CD4 Rapid Test is a semi-quantitative assay for the estimation of CD4 protein on the surface of CD4+ T cells in human whole blood to indicate whether the level is above or below 350 cells/ µL within pre-diagnosed HIV patients.
VISITECT® CD4 benefits people living with HIV and healthcare providers
Accelerate clinical disease management
Faster decision-making, reduce burden on healthcare workers
Reduce patient loss to follow-up?
Improve patient retention??
Test anywhere, anytime?
Convenient, disposable and read by eye?
Reduce costs?
Zero investment in equipment, no sample transport required
Improve patient outcomes?
Patients are prioritised for Antiretroviral Therapy (ART) initiation.
